Center for Excellence in Molecular Cell Science, CAS, China
Dr Lijian Hui is the PI in Shanghai Institute of Biochemistry and Cell Biology (SIBCB). He is currently the president of Chinese Association of Cell and Gene Therapy, editorial board member of Cell Stem Cell, Hepatology etc.
Dr. Hui studies molecular pathology of liver diseases, with the focus on cell identity conversion, i.e., dedifferentiation and transdifferentiation, in liver regeneration and tumorigenesis. His team demonstrated the conversion from fibroblasts into hepatocytes in vitro, thereby providing one of the first evidence of transdifferentiation in mammalian cells. His team is also among the first to report cell identity conversion in liver injury and repair. Dr. Hui has authored over 100 articles and recieved several awards.
MANUFACTURING WITH COMMERCIALIZATION IN MIND
Friday, June 13, 2025
8:30 AM – 10:00 AM HK Time
CELL IDENTITY CONVERSION: LIVER REGENERATION AND CELL THERAPY
Friday, June 13, 2025
8:30 AM – 10:00 AM HK Time
PLENARY III: ADULT HOMEOSTASIS: STEM CELLS IN PHYSIOLOGY AND DISEASE
Friday, June 13, 2025
10:30 AM – 12:00 PM HK Time